smoking cessation News
Most Popular smoking cessation Story
Cytos plummets on Phase II vax failure
Switzerland's Cytos Biotechnology (CYTN) stock was punished on the news that it's anti-smoking vaccine failed to hit its primary endpoint in a Phase II trial. This endpoint was defined as a Read more...
Latest Headlines
- November 28, 2011
- September 29, 2011
- October 16, 2009
- May 23, 2008
- January 24, 2008
- January 23, 2008
- December 7, 2007
- November 9, 2007
- October 1, 2007
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
